Загрузка...
Immunotherapy and pancreatic cancer: unique challenges and potential opportunities
Despite decades of research, pancreatic ductal adenocarcinoma (PDAC) continues to have the worst 5-year survival of any malignancy. With 338,000 new cases diagnosed and over 300,000 deaths per year globally there is an urgent unmet need to improve the therapeutic options available. Novel immunothera...
Сохранить в:
| Опубликовано в: : | Ther Adv Med Oncol |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
SAGE Publications
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6299311/ https://ncbi.nlm.nih.gov/pubmed/30574212 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835918816281 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|